KB Dialysis Portfolio, DST
KB Dialysis Portfolio, DST is a real estate fund based in Las Vegas, Nevada. Its most recent Form D, filed Apr 7, 2016, reports no sales yet. The minimum investment it accepts from an outside investor is $10,000. The offering uses Rule 506(c), which permits general advertising to investors verified as accredited. Related persons named in the filing include Mark Paul; KB Exchange Holdings, LLC; Kingsbarn Realty Capital, LLC.
- Total raised
- $0Cumulative sales reported on Form D
- Investors
- 0
- First sale
- —
- Minimum investment
- $10,000
- Who can invest
- Not stated
- Offering exemption
- Rule 506(c)May advertise; investors must be verified as accredited
- Key people and entities
- Mark Paul; KB Exchange Holdings, LLC; Kingsbarn Realty Capital, LLC
- Latest Form D
- Apr 7, 2016
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about KB Dialysis Portfolio, DST
What is the minimum investment for KB Dialysis Portfolio, DST?
According to its latest Form D, filed Apr 7, 2016, the minimum investment KB Dialysis Portfolio, DST accepts from an outside investor is $10,000.
Who can invest in KB Dialysis Portfolio, DST?
KB Dialysis Portfolio, DST is generally open only to investors who meet the eligibility rules in its offering documents. It uses Rule 506(c), so it may advertise, but every investor must be verified as accredited.
How much has KB Dialysis Portfolio, DST raised?
KB Dialysis Portfolio, DST's latest Form D, filed Apr 7, 2016, reports no sales yet.
Where is KB Dialysis Portfolio, DST based?
KB Dialysis Portfolio, DST is based in Las Vegas, Nevada.
Size compared with every real estate fund
This fund hasn't reported any sales yet.